At the Colorado Blood Cancer Institute we perform autologous stem cell transplant for certain autoimmune disorders including but not limited to: Scleroderma, Stiff Person Syndrome and Multiple Sclerosis. The program is led by Dr. Richard Nash and is in collaboration with The Fred Hutchinson Cancer Research Center and other transplant, neurologic, and rheumatologic centers around the country.
Autoimmune diseases can take several different forms, and even within the same disease type, the progression and severity of symptoms can vary greatly from patient to patient. In some patients, symptoms will develop rapidly, and they may fail conventional therapy. These patients may be eligible for high-dose chemotherapy and autologous hematopoietic stem cell transplantation (AHCT) as part of a clinical trial or as standard therapy.